Well, I can give you my ratings for HERB which will give you a quick overview. 7.5 = buy
Valuation = 11.1
Growth = 8
Risk = 7.5
Adaptability = 8
Priority = 11
Reliability earnings = 9
Overall score = 8.83 (Very close to SIAF = 8.87)
Usually a score of 10 would be max. Priority = 11 though because of the potential merger which could create value for shareholders very fast.
Besides the fruit and vegetables, I like a couple of projects. Hemp, Angel dust, Cattle. I don't care about the rest. Neither do I know much about it because I do selective DD mostly.
Usually I wouldn't invest more than 10% here. But it seems obvious now that Gansu Yasheng (with a listing in Shanghai) is managed by the same bunch, which reduces risk. I also had to upgrade the stock because of the potential merger, which shows they can adapt.
What's not to like here from a risk/reward perspective?
But that's just my opinion.
Recent HERB News
- Form C-AR - Annual Report • Edgar (US Regulatory) • 02/26/2024 01:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 08:51:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 07:00:08 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM